Theranos is reportedly shaking up its board of directors amid criticism over its lab-testing technology

Theranos, the lab-testing company currently embroiled in questions about the legitimacy of its test methods, is reportedly preparing to shake up its board of directors.

According to a report from The New York Times, Theranos will announce that board members Henry Kissinger and George Schultz are among those who will exit.

Despite the changes - which come at a time when Theranos is operating under increased scrutiny from the FDA - the board reportedly says in a statment that it continues to support Theranos CEO, Elizabeth Holmes.

The statement, cited by The Times, says in part: "We stand wholeheartedly behind the management, achievements, vision and commitment of this company."

More to come ...